The clinical application of virtual reality technology for treatment and rehabilitation purposes, including exposure therapy for phobias and PTSD, distraction-based pain management, cognitive behavioural therapy delivered in immersive digital environments, and motor rehabilitation. FDA regulatory authorisation and CMS billing codes established from 2021 onwards have formalised therapeutic VR as a reimbursable clinical modality.
Semantic Classification
Content
Overview
- VR is being used to treat anxiety, PTSD, substance use disorders, autism, phobias, and various mood disorders. The FDA granted marketing authorization for VR therapy in 2021, and CMS created a billing code for VR cognitive behavioral therapy devices effective April 2023.
Technical Details
Treatment Applications
- Exposure Therapy: Customizable VR scenarios for phobia and PTSD treatment
- Cognitive Behavioral Therapy: Interactive VR environments for therapeutic interventions
- Pain Management: Distraction and relaxation therapy for chronic pain
- Rehabilitation: Physical and occupational therapy in virtual environments
Key Developments (2024)
- RelieVRx: FDA-authorized VR program for chronic lower back pain with HCPSC billing code
- Telehealth Integration: VR combined with telepsychiatry for remote therapy
- Avatar-Based Therapy: Anonymity and immersion for patients avoiding traditional care
Clinical Benefits
- Controlled, reproducible therapeutic scenarios
- Individualized treatment customization
- Safe environment for exposure therapy
- Measurable physiological response tracking
Applications
- PTSD treatment for veterans and trauma survivors
- Phobia desensitization programs
- Palliative care mental health support
- Addiction treatment and prevention
- Anxiety and depression interventions